Gene Expression Changes in Colon Cancer Cells Treated with SN-38
Author Information
Author(s): Vinicius Souza, Dong Yan Bin, Zhou H Sam, Zacharias Wolfgang, McMasters Kelly M
Primary Institution: University of Louisville School of Medicine
Hypothesis
The study aims to evaluate changes in gene expression in SW-620 cells in response to SN-38 to understand its mechanisms of inducing apoptosis and cell cycle arrest.
Conclusion
The study enhances understanding of the biochemical pathways involved in SN-38-induced apoptosis and may help identify new therapeutic targets.
Supporting Evidence
- 192 genes showed over a 2-fold change in expression after SN-38 treatment.
- Most affected genes were related to DNA replication, transcription, signal transduction, and apoptosis.
- 14 genes' expression changes were confirmed by quantitative real-time PCR.
Takeaway
This study looked at how a cancer drug called SN-38 changes the way certain genes work in cancer cells, which helps us understand how it can kill those cells.
Methodology
The study used a quantitative gene expression microarray assay and confirmed results with RT-PCR to analyze gene expression changes in SW-620 colon cancer cells after SN-38 treatment.
Statistical Information
P-Value
<0.006
Statistical Significance
p<0.006
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website